VX-702, CAS [[745833-23-2]]

Produktübersicht

• Artikelname: VX-702, CAS [[745833-23-2]]
• Artikelnummer: TGM-T2513
• Hersteller Artikelnummer: T2513
• Alternativnummer: TGM-T2513-1MLX10MM(INDMSO),TGM-T2513-5MG,TGM-T2513-10MG,TGM-T2513-25MG,TGM-T2513-50MG,TGM-T2513-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: 479543-46-9

Produktbeschreibung

VX-702 is a highly specific p38alpha MAPK inhibitor, 14-fold higher selectivity for the p38alpha than p38beta. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).

Produkteigenschaften

• Molekulargewicht: 404.32
• Reinheit: 98.96%
• CAS Nummer: [745833-23-2]
• Formel: C19H12F4N4O2
• Target-Kategorie: Autophagy|||p38 MAPK

Bilder

T2513